Short Description

NGS genetic DNA test detecets for variant and mutation detection in CD79A gene for Agammaglobulinemia type 3, autosomal recessive

PreTest Information

Clinical History of Patient who is going for CD79A Gene Agammaglobulinemia type 3, autosomal recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD79A Gene Agammaglobulinemia type 3, autosomal recessive NGS Genetic DNA Test gene CD79A

Detail Description

CD79A Gene Agammaglobulinemia Type 3 - Symptoms, Diagnosis and NGS Genetic DNA Test Cost

CD79A Gene Agammaglobulinemia Type 3 is an autosomal recessive genetic disorder that affects the immune system. It is caused by mutations in the CD79A gene, which is responsible for the production of a protein called Ig-alpha. This protein is essential for the development and function of B cells, which are responsible for producing antibodies that fight off infections.

People with CD79A Gene Agammaglobulinemia Type 3 have a weakened immune system, which makes them more susceptible to infections. The symptoms of this disorder typically appear in early childhood and include:

• Recurrent bacterial infections, such as ear infections, sinus infections, and pneumonia
• Recurrent viral infections, such as colds and flu
• Chronic diarrhea and other gastrointestinal problems
• Failure to thrive and poor growth

If you or your child are experiencing any of these symptoms, it is important to consult a doctor for diagnosis and treatment.

The diagnosis of CD79A Gene Agammaglobulinemia Type 3 is typically made through genetic testing. This may include a blood test to look for mutations in the CD79A gene, as well as other tests to evaluate the immune system and identify any infections present.

At DNA Labs India, we offer NGS genetic DNA testing for CD79A Gene Agammaglobulinemia Type 3. This test uses next-generation sequencing technology to analyze the entire CD79A gene and identify any mutations present. The cost of this test is INR 20,000.

If you suspect that you or your child may have CD79A Gene Agammaglobulinemia Type 3, it is important to seek a diagnosis and treatment as soon as possible. With early intervention, many of the complications associated with this disorder can be prevented.

D79A gene encodes a protein called CD79A, which is a component of the B-cell receptor complex found on the surface of B cells. B cells are a type of white blood cell responsible for producing antibodies.

Mutations in the CD79A gene can lead to Agammaglobulinemia Type 3, Autosomal Recessive, where the function of B cells is impaired, resulting in a deficiency of mature B cells and a lack of effective antibody production.

NGS (Next-Generation Sequencing) genetic DNA tests are used to analyze the DNA sequence of genes like CD79A to identify any mutations or variants that may be associated with Agammaglobulinemia Type 3, Autosomal Recessive.

If you or someone you know is considering genetic testing for Agammaglobulinemia related to the CD79A gene, I recommend consulting with an immunologist, a medical geneticist, or a genetic counselor. They can provide accurate and current information about the condition, the implications of genetic testing, and any available treatment options. Medical knowledge can evolve, so it's important to rely on expert guidance for the latest information.